Unibios Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Unibios Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Machinery earnings growth | 11.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Investor Optimism Abounds Unibios Holdings S.A. (ATH:BIOSK) But Growth Is Lacking
Jan 05
Unibios Holdings (ATH:BIOSK) Takes On Some Risk With Its Use Of Debt
Oct 05Investors Will Want Unibios Holdings' (ATH:BIOSK) Growth In ROCE To Persist
Jul 26Returns Are Gaining Momentum At Unibios Holdings (ATH:BIOSK)
Nov 17Returns At Unibios Holdings (ATH:BIOSK) Are On The Way Up
May 20Unibios Holdings (ATH:BIOSK) May Have Issues Allocating Its Capital
Jan 04Unibios Holdings (ATH:BIOSK) Has Some Difficulty Using Its Capital Effectively
Aug 21Unibios Holdings (ATH:BIOSK) Use Of Debt Could Be Considered Risky
May 05Returns On Capital At Unibios Holdings (ATH:BIOSK) Paint An Interesting Picture
Mar 01In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Unibios Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 13 | 2 | 1 | 1 | N/A |
| 9/30/2023 | 13 | 1 | 0 | 0 | N/A |
| 6/30/2023 | 13 | 1 | -1 | -1 | N/A |
| 3/31/2023 | 12 | 1 | -2 | -1 | N/A |
| 12/31/2022 | 11 | 1 | -2 | -2 | N/A |
| 9/30/2022 | 10 | 0 | -1 | -1 | N/A |
| 6/30/2022 | 9 | 0 | 0 | 0 | N/A |
| 3/31/2022 | 9 | 0 | 1 | 1 | N/A |
| 12/31/2021 | 8 | 0 | 1 | 1 | N/A |
| 9/30/2021 | 8 | 0 | 1 | 1 | N/A |
| 6/30/2021 | 8 | 0 | 0 | 1 | N/A |
| 3/31/2021 | 8 | 0 | 0 | 0 | N/A |
| 12/31/2020 | 7 | 0 | 0 | 0 | N/A |
| 9/30/2020 | 7 | 0 | -1 | -1 | N/A |
| 6/30/2020 | 7 | 0 | -1 | -1 | N/A |
| 3/31/2020 | 8 | 0 | -1 | -1 | N/A |
| 12/31/2019 | 8 | 0 | -1 | -1 | N/A |
| 9/30/2019 | 8 | 0 | -1 | -1 | N/A |
| 6/30/2019 | 7 | 0 | 0 | 0 | N/A |
| 3/31/2019 | 8 | 0 | -1 | -1 | N/A |
| 12/31/2018 | 8 | 0 | -1 | -1 | N/A |
| 9/30/2018 | 8 | 0 | -1 | -1 | N/A |
| 6/30/2018 | 7 | 0 | -1 | -1 | N/A |
| 3/31/2018 | 6 | 0 | -1 | 0 | N/A |
| 12/31/2017 | 5 | 0 | -1 | 0 | N/A |
| 9/30/2017 | 5 | -1 | N/A | 0 | N/A |
| 6/30/2017 | 5 | -2 | N/A | 0 | N/A |
| 3/31/2017 | 5 | -2 | N/A | 0 | N/A |
| 12/31/2016 | 5 | -2 | N/A | 0 | N/A |
| 9/30/2016 | 6 | 0 | N/A | 0 | N/A |
| 6/30/2016 | 6 | 0 | N/A | 0 | N/A |
| 3/31/2016 | 7 | 0 | N/A | -1 | N/A |
| 12/31/2015 | 6 | 0 | N/A | 0 | N/A |
| 9/30/2015 | 7 | -1 | N/A | 0 | N/A |
| 6/30/2015 | 8 | -1 | N/A | 1 | N/A |
| 3/31/2015 | 8 | 0 | N/A | 1 | N/A |
| 12/31/2014 | 8 | 0 | N/A | 0 | N/A |
| 9/30/2014 | 9 | 0 | N/A | 0 | N/A |
| 6/30/2014 | 9 | 0 | N/A | 0 | N/A |
| 3/31/2014 | 9 | 0 | N/A | 0 | N/A |
| 12/31/2013 | 9 | 0 | N/A | 0 | N/A |
| 9/30/2013 | 8 | -1 | N/A | 0 | N/A |
| 6/30/2013 | 8 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BIOSK's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if BIOSK's earnings are forecast to grow faster than the Greek market
High Growth Earnings: Insufficient data to determine if BIOSK's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BIOSK's revenue is forecast to grow faster than the Greek market.
High Growth Revenue: Insufficient data to determine if BIOSK's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIOSK's Return on Equity is forecast to be high in 3 years time